Dare Bioscience, Inc. Current Liabilities
Dare Bioscience, Inc. (DARE) had Current Liabilities of $16.92 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2026-08-13
- 2026-06-30: Liabilities, Current $16.92M.
- 2026-03-31: Liabilities, Current $21.12M.
- 2025-12-31: Liabilities, Current $23.69M.
- 2025-09-30: Liabilities, Current $21.22M.
| Period end | Liabilities, Current | Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $16.92M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $21.12M 10-Q · filed 2026-05-14 | |
| 2025-12-31 | $23.69M 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $21.22M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $19.22M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $21.19M 10-Q · filed 2025-05-13 | |
| 2024-12-31 | $21.61M 10-K · filed 2026-03-26 | $21.61M 10-K · filed 2025-03-31 |
| 2024-09-30 | $13.16M 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $14.59M 10-Q · filed 2024-08-12 | |
| 2024-03-31 | $17.72M 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $20.48M 10-K · filed 2025-03-31 | |
| 2023-09-30 | $26.34M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $24.70M 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $24.34M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $31.62M 10-K · filed 2024-03-28 | |
| 2022-09-30 | $22.84M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $16.54M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $16.39M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $16.05M 10-K · filed 2023-03-30 | |
| 2021-09-30 | $15.91M 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $6.00M 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $6.11M 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $7.66M 10-K · filed 2022-03-31 | |
| 2020-09-30 | $7.96M 10-Q · filed 2020-11-12 | |
| 2020-06-30 | $6.08M 10-Q · filed 2020-08-12 | |
| 2020-03-31 | $4.72M 10-Q · filed 2020-05-14 | |
| 2019-12-31 | $5.61M 10-K · filed 2021-03-30 | |
| 2019-09-30 | $1.89M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $1.97M 10-Q · filed 2019-08-14 | |
| 2019-03-31 | $1.02M 10-Q · filed 2019-05-14 | |
| 2018-12-31 | $1.09M 10-K · filed 2020-03-27 | |
| 2018-09-30 | $1.20M 10-Q · filed 2018-11-13 | |
| 2018-06-30 | $1.27M 10-Q · filed 2018-08-13 | |
| 2018-03-31 | $807.61K 10-Q · filed 2018-05-14 | |
| 2017-12-31 | $966.65K 10-K · filed 2019-04-01 | |
| 2017-09-30 | $839.37K 10-Q · filed 2017-11-13 | |
| 2017-06-30 | $1.49M 8-K/A · filed 2017-10-02 | $3.35M 10-Q · filed 2017-08-14 |
| 2017-03-31 | $6.68M 10-Q · filed 2017-05-12 | |
| 2016-12-31 | $755.24K 10-K · filed 2018-03-28 | $16.94M 10-K · filed 2017-03-31 |
| 2016-09-30 | $15.89M 10-Q · filed 2016-11-03 | |
| 2016-06-30 | $14.46M 10-Q · filed 2016-08-04 | |
| 2016-03-31 | $15.58M 10-Q · filed 2016-05-02 | |
| 2015-12-31 | $516.36K 8-K/A · filed 2017-10-02 | $16.34M 10-K · filed 2016-03-10 |
| 2015-09-30 | $10.61M 10-Q · filed 2015-11-16 | |
| 2015-06-30 | $7.84M 10-Q · filed 2015-08-06 | |
| 2015-03-31 | $5.29M 10-Q · filed 2015-05-06 | |
| 2014-12-31 | $8.06M 10-K · filed 2016-03-10 | |
| 2014-09-30 | $6.38M 10-Q · filed 2014-11-13 | |
| 2014-06-30 | $5.96M 10-Q · filed 2014-08-12 | |
| 2014-03-31 | $24.18M 10-Q · filed 2014-05-27 | |
| 2013-12-31 | $15.15M 10-K · filed 2015-03-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |